3 excellent ASX shares to buy for your SMSF

Analysts think these shares could be top picks for SMSF investors. Let's find out why.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

For Australia's growing community of self-managed super fund (SMSF) trustees, long-term thinking is everything.

With over 625,000 SMSFs holding a collective $990 billion in assets as of 30 June 2024, according to the ATO, more Australians than ever are taking control of their retirement outcomes — and doing so with an eye on quality, sustainability, and growth.

If you're managing your own super, choosing the right ASX shares can make a significant difference to your wealth over time.

The goal? Own companies with durable advantages, strong leadership, and clear growth runways that can compound for years to come.

With that in mind, here are three excellent ASX shares that analysts think could make strong long-term additions to any SMSF portfolio. They are as follows:

Two people having a meeting using a laptop and tablet to discuss Seven West Media's balance sheet

Image source: Getty Images

Goodman Group (ASX: GMG)

Goodman Group is a standout in the property space. Instead of shopping centres or office towers, it focuses on high-demand industrial assets like warehouses, distribution centres, and data infrastructure.

It is a pure play on the rise of e-commerce, supply chain modernisation, and the cloud economy. Major global names like Amazon and Microsoft are Goodman tenants, and the company has a development pipeline geared towards supporting data centre.

Citi currently rates Goodman as a buy with a $40.00 price target.

ResMed Inc. (ASX: RMD)

Another ASX SMSF share to look at is ResMed. It is a global leader in sleep and respiratory medicine, known for its innovative CPAP machines and digital health solutions. The company's technology helps millions of people around the world manage sleep apnoea and chronic respiratory conditions — and demand is only rising.

For SMSF investors looking to invest in healthcare innovation with global scale and recurring revenue, ResMed ticks all the boxes.

Goldman Sachs rates the company very highly. It has a conviction buy rating and $49.30 price target on its shares.

Xero Ltd (ASX: XRO)

Finally, Xero could be an ASX share to buy for an SMSF. It has grown into one of Australia and New Zealand's biggest tech success stories — and there's still a long road ahead. The company provides cloud-based accounting software to just over 4 million subscribers globally, with deep penetration across ANZ and increasing traction in key international markets.

Xero generates recurring, high-margin revenue, and while it's still investing for growth, the business is now focused on profitability and operating leverage. Its customer base of small and medium businesses is loyal, sticky, and growing — making it a compelling software-as-a-service (SaaS) play for long-term investors.

Goldman Sachs estimates that it has a 100 million total addressable market. This gives it a significant growth runway over the next decade or two.

It is for this reason that Goldman has a buy rating and $201.00 price target on its shares.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in Goodman Group, ResMed, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Goodman Group, ResMed, and Xero. The Motley Fool Australia has positions in and has recommended ResMed and Xero. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.
Growth Shares

Top Australian shares to buy right now with $2,500

These shares look attractive after recent market volatility.

Read more »

Person using a calculator with four piles of coins, each getting higher, with trees on them.
Growth Shares

Experts rate these 2 ASX growth shares as buys this month!

These businesses have plenty of positives according to analysts.

Read more »

A man sits in contemplation on his sofa looking at his phone as though he has just heard some serious or interesting news.
Growth Shares

3 ASX shares being unfairly punished by the market selloff and could rise 100%

Analysts think these shares could rebound strongly after heavy declines.

Read more »

Two players on a field pump their fists in the air, indicating two of the best
Growth Shares

2 amazing ASX shares to buy for long-term growth

Both billion dollar stocks combine strong growth, scalability and a leadership position.

Read more »

A beautiful woman holds up one finger with one hand and has her hand on her waist with the other as she smiles widely as though she is very pleased about something.
Growth Shares

2 ASX 200 shares that now have 60% upside: Analysts

With markets under pressure, some ASX 200 shares are starting to look more interesting. Here are two that stand out…

Read more »

Man looking amazed holding $50 Australian notes, representing ASX dividends.
Growth Shares

Where to invest $10,000 in ASX shares right now

These quality shares could be worth considering. Let's find out why.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Growth Shares

$3k to invest? 2 ASX shares to consider buying in 2026

These shares have been sold off and could offer major upside according to analysts.

Read more »

One girl leapfrogs over her friend's back.
Growth Shares

This dirt cheap ASX retail stock is tipped to double in value

Better execution and easing pressures could spark a powerful rebound.

Read more »